Sarepta Therapeutics, Inc.

215 First Street
United States

Tel: 617-274-4000


Show jobs for this employer

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and CNS. The Company now has 23 programs in development across several therapeutic modalities, including RNA, gene therapy and gene editing.

Sarepta is writing a new play book, one that has the potential to define rare disease drug development.

  • We place the patient front and center to everything we do and every decision we make.
  • We are a science-driven organization.
  • We work with a bias to action.  
  • We attract employees who want to make a difference and aren't afraid of upsetting the “norm” - we like disrupters.
  • We invest heavily in R&D and are pursuing a model where the pathway is defined and the science compelling.

Sarepta's largest employee population is based in Massachusetts with headquarters in Cambridge and a manufacturing and laboratory facility in Andover, with plans to build a gene therapy Research Center of Excellence in Columbus, Ohio. The Company is also establishing its global presence with new offices in Brazil, Ireland, UK, Germany, France, Italy, and the Nordics, with European headquarters in Zug, Switzerland.

Corporate Mission Statement: 

Leading the field of precision medicine to forever change the course of rare disease so patients can dream big, live fully and journey far.

Stock Symbol: SRPT

Stock Exchange: NASDAQ


Check out careers with Sarepta here.

World Duchenne Awareness Day (WDAD) at Sarepta Therapeutics

Sarepta raises awareness for Duchenne muscular dystrophy (DMD) on World Duchenne Awareness Day - September 2018

614 articles with Sarepta Therapeutics, Inc.